At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Two Contrasting Intervention Programs for Sleep Management
In Brief
A Phase 3 clinical trial evaluating Zolpidem and Mind-Body Bridging for Primary Insomnia and Secondary Insomnia. Completed, enrolled 72 participants across 2 sites.
Detailed Summary
This study will determine whether Mind-Body Bridging (MBB), a mindfulness training program is more effective than a common sleep medication, Zolpidem, in treating insomnia. It will also investigate whether MBB is additionally beneficial for co-morbid conditions such as stress, PTSD, depression, etc, compared with that of Zolpidem.
Study Details
Timeline
Interventions
Week 1: 10 mg Zolpidem daily for 1 week, Week 2: 10 mg Zolpidem daily for one week, taken as needed, Week 3: 5 mg Zolpidem daily for 1 week, taken as needed.
An awareness training program. One 2 hr class per week for 3 weeks - 2 hours per session